debate: best approach for multiple relapsed cll after chemoimmunotherapy - other novel agents
Published 9 years ago • 84 plays • Length 19:14Download video MP4
Download video MP3
Similar videos
-
14:03
debate: best approach for multiple relapsed cll after chemoimmunotherapy - asct
-
11:23
debate: best approach for multiple relapsed cll after chemoimmunotherapy - kinase inhibitor
-
13:55
debate: optimal approach for the management of cll patients with del(17p) - novel agents
-
21:19
cll: sequencing monotherapy vs. combination therapy
-
24:17
combination of novel agents in cll: is this the final answer?
-
28:57
prison reform: alternatives to mass incarceration with steven raphael
-
6:11
'the best defense is the truth;' private prison company sues activist for libel & loses | msnbc
-
7:05
debate: incarceration in america
-
12:08
debate: which is the optimal approach for cll? - br
-
15:02
debate: will novel-agent based combination therapy become standard of care for cll? - no
-
14:02
debate: best frontline regimen for a cll patient aged 60 who requires therapy - fcr
-
19:42
treatment options for the young cll patient with deletion 17p: do they need a different approach?
-
18:48
debate: relapsed 60 y/o follicular lymphoma patient after upfront r-chop - novel agents
-
14:13
debate: do we have enough data to eliminate chemotherapy from initial treatment for cll? - yes
-
14:48
debate: best frontline regimen for a cll patient aged 60 who requires therapy - ibrutinib
-
16:07
treatment strategies for relapsed/refractory cll
-
25:38
cll: chemotherapy and ibrutinib based regimens
-
14:18
debate: young patient with recurrent follicular lymphoma and short remission? - novel agents/chemo
-
21:37
how i approach upfront and relapsed dlbcl
-
22:46
follicular lymphoma debate: does chemotherapy have a major role to play?
-
12:59
debate: do we have enough data to eliminate chemotherapy from initial treatment for cll? - no
-
49:01
chronic lymphocytic leukemia: case discussions